These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31322514)

  • 1. [SERUM CONTENTS OF SUBSTANCE P, ENDOTHELIN-1 AND VASOACTIVE INTESTINAL PEPTIDE IN CHILDREN WITH RECURRENT BRONCHITIS AND VERTEBROBASILAR INSUFFICIENCY].
    Slutskaya T; Ovcharenko L; Vertehel A; Kryazhev A; Samokhin I
    Georgian Med News; 2019 May; (290):48-52. PubMed ID: 31322514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basal concentration of Substance P (SP) and Vasoactive Intestinal Peptide (VIP) in the blood serum of children with allergic dermatitis].
    Grzybowska-Chłebowczyk U; Woś H; Szymańska M; Kajor M
    Med Wieku Rozwoj; 2003; 7(1):43-8. PubMed ID: 13130168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide chronomics in clinically healthy young adults: circaoctohoran and circadian patterns.
    Löckinger A; Köberle D; König PS; Saria A; Herold M; Cornélissen G; Halberg F
    Peptides; 2004 Apr; 25(4):533-42. PubMed ID: 15165707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study on the effect of non-adrenergic non-cholinergic nerves in asthma].
    Liu A; Li PS; Zhang ZJ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):223-5. PubMed ID: 7512457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinical study on determination of plasma vasoactive intestinal peptide and the relationship between plasma vasoactive intestinal peptide and bronchial responsiveness in asthmatics].
    Liu A; Li PS; Zhang ZJ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):165-6. PubMed ID: 8222979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders.
    Ko FJ; Chiang CH; Liu WJ; Chiang W
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Aug; 7(8):391-7. PubMed ID: 1714968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum substance P and vasoactive intestinal peptide levels in infants with acute intussusception.
    Zhu ZC; Wang HB; Yan XQ; Yang J; Duan XF; Bian HQ; Kuang HF
    J Int Med Res; 2019 Jun; 47(6):2446-2451. PubMed ID: 31006358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of electroacupuncture on plasma vasoactive intestinal peptide and substance P in perennial allergic rhinitis patients].
    Li YM; Zhuang LX; Lai XS; Jiang GH
    Zhen Ci Yan Jiu; 2007 Apr; 32(2):136-8. PubMed ID: 17650661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective localization of vasoactive intestinal peptide and substance P in human eosinophils.
    Aliakbari J; Sreedharan SP; Turck CW; Goetzl EJ
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1440-5. PubMed ID: 2446611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do substance P and vasoactive intestinal polypeptide (VIP) play a role in the acute occlusive or chronic ischaemic vasodilation in man?
    Henriksen JH; Bülow JB; Schaffalitzky de Muckadell O; Fahrenkrug J
    Clin Physiol; 1986 Apr; 6(2):163-70. PubMed ID: 2420506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease.
    Wallengren J; Ekman R; Möller H
    Acta Derm Venereol; 1986; 66(1):23-8. PubMed ID: 2424210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease.
    Hernanz A; De Miguel E; Romera N; Perez-Ayala C; Gijon J; Arnalich F
    Br J Rheumatol; 1993 Jan; 32(1):31-5. PubMed ID: 7678534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early increase and later decrease in VIP and substance P nerve fiber densities following abdominal radiotherapy: a study on the human colon.
    Höckerfelt U; Franzén L; Norrgård O; Forsgren S
    Int J Radiat Biol; 2002 Nov; 78(11):1045-53. PubMed ID: 12456292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training].
    Haustein UF; Weber B; Seikowski K
    Hautarzt; 1995 Feb; 46(2):102-6. PubMed ID: 7535759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases.
    Chanez P; Springall D; Vignola AM; Moradoghi-Hattvani A; Polak JM; Godard P; Bousquet J
    Am J Respir Crit Care Med; 1998 Sep; 158(3):985-90. PubMed ID: 9731035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P-selectin and tachykinins in bronchial hyperresponsiveness of asthma].
    Yu H; Ren J; Wang F; Liu L; Wu S; Liu Y
    Zhonghua Nei Ke Za Zhi; 1999 Apr; 38(4):228-30. PubMed ID: 11798650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreases in substance P and vasoactive intestinal peptide concentrations in plasma of stroke-prone spontaneously hypertensive rats.
    Mori K; Asakura S; Ogawa H; Sasagawa S; Takeyama M
    Jpn Heart J; 1993 Nov; 34(6):785-94. PubMed ID: 7513029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P and vasoactive intestinal peptide in nasal secretions and plasma from patients with nasal allergy.
    Chaen T; Watanabe N; Mogi G; Mori K; Takeyama M
    Ann Otol Rhinol Laryngol; 1993 Jan; 102(1 Pt 1):16-21. PubMed ID: 7678375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions.
    Tønnesen P; Hindberg I; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1988 May; 43(4):310-7. PubMed ID: 2455456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of terfenadine on the plasma concentrations of substance P and vasoactive intestinal polypeptide in volunteers.
    Mori K; Asakura S; Morikawa N; Takeyama M
    J Pharm Pharmacol; 1992 Oct; 44(10):856-8. PubMed ID: 1280680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.